Skip to content

Clarification of gut microbiota in patients with esophageal cancer closely related to a life style.

Clarification of gut microbiota in patients with esophageal cancer closely related to a life style. - Clarification of gut microbiota in patients with esophageal cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000036882
Enrollment
20
Registered
2020-03-31
Start date
2019-01-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

None listed

Sponsors

Kyushu University
Lead Sponsor
Fukuoka Dental College Hospital Biofermin Pharmaceutical Co., Ltd.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) The patients who are diagnosed esophageal cancer and planned to be treated in Kyusyu University Hospital or Fukuoka Dental College Hospital 2) The person who understand the details of the study and have the ability to provide informed consent

Exclusion criteria

Exclusion criteria: 1) The patients who are pregnant or may be pregnant 2) The patients with psychiatric disorders. 3) The patients who are judged that participation in the study is inadequate by the medical attendant

Design outcomes

Primary

MeasureTime frame
The characteristics of gut microbiota in patient with esophageal cancer The effect of chemoradiation therapy and surgery on gut microbiota in patient with esophageal cancer

Secondary

MeasureTime frame
Correlation with gut microbiota and surgical outcome, survival, clinical findings, blood biochemistry finding and presence of gastrointestinal symptoms

Countries

Japan

Contacts

Public ContactHirofumi Hasuda

Graduate School of Medical Sciences, Kyushu University Department of Surgery and Science

h-hasuda@surg2.med.kyushu-u.ac.jp092-642-5466

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026